GleamWall
中文EN

AVR Anteris Technologies Global Corp.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 2011514 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.0%
TTM net income YoY-28.3%
TTM EPS YoY36.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin75.8%
Operating margin-4,880.4%
Net margin-4,637.5%
FCF margin-4,008.4%
EBITDA margin-4,802.4%

Returns

ROE-93.8%
ROA-76.8%
ROIC (approx.)-3,856.3%
Asset turnover0.02x

Leverage & solvency

Liabilities / assets13.5%
Debt / equity0.00x
Current ratio12.45x
Interest coverage-615.19x

Cash quality & payout

Operating cash flow / net income0.84x
Accruals ratio-12.3%
Payout ratio—
Capex / revenue110.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$519,000$1.01M$494,000$310,000$429,000$618,000$556,000$536,000
Cost of revenue$126,000$233,000$114,000$91,000$123,000$148,000$207,000$208,000
Gross profit$393,000$776,000$380,000$219,000$306,000$470,000$349,000$328,000
R&D expense$21.33M$23.37M$17.46M$19.51M$16.81M$16.34M$16.46M$13.32M
SG&A expense$8.90M$8.40M$6.93M$9.67M$5.76M$5.01M$5.67M$8.53M
Operating income-$29.84M-$31.00M-$24.01M-$28.96M-$22.27M-$20.88M-$21.78M-$21.52M
Interest expense$17,000$131,000$27,000$10,000$15,000$22,000$26,000$8,000
Pretax income-$27.10M-$28.78M-$22.41M-$29.02M-$22.21M-$21.06M-$21.93M-$19.20M
Income tax-$272,000$0$492,000$0$0$0$0$0
Net income-$26.83M-$29.09M-$23.02M-$29.20M-$22.24M-$20.83M-$21.86M-$19.38M
EBITDA-$29.34M-$30.53M-$23.58M-$28.54M-$21.85M-$20.47M-$21.38M-$21.11M
EPS (basic)-0.28-0.30-0.28—-0.62-0.58-0.61—
EPS (diluted)-0.28-0.30-0.28—-0.62-0.58-0.61—
Weighted avg. shares (diluted)97.46M97.34M83.01M—36.06M36.06M36.01M—
Balance sheet
Cash & equivalents$216.99M$249.90M$283.21M$6.70M$9.12M$28.44M$48.95M$70.46M
Receivables$220,000$548,000$231,000$32,000$234,000$687,000$189,000$208,000
Inventory$0$8,000$122,000$152,000$436,000$449,000$364,000$513,000
Current assets$237.58M$260.65M$286.67M$15.68M$11.22M$32.21M$52.98M$74.65M
PP&E, net$5.68M$5.62M$5.18M$5.26M$5.29M$4.93M$4.66M$4.77M
Intangibles$89,000$97,000$105,000$65,000$70,000$98,000$142,000$189,000
Total assets$262.46M$272.51M$294.72M$23.00M$19.07M$39.88M$58.79M$80.70M
Current liabilities$19.09M$18.36M$13.69M$21.37M$13.43M$13.34M$14.43M$16.56M
Short-term debt$117,000$404,000$707,000$16,000$96,000$387,000$690,000$3,000
Long-term debt$61,000$47,000$18,000$22,000$26,000$30,000$30,000$0
Total debt$178,000$451,000$725,000$38,000$122,000$417,000$720,000$3,000
Total liabilities$35.41M$20.84M$16.31M$23.25M$15.71M$15.85M$15.68M$18.02M
Shareholders' equity$226.77M$251.39M$278.44M-$93,000$3.70M$24.41M$43.26M$62.76M
Net debt-$216.81M-$249.45M-$282.49M-$6.66M-$9.00M-$28.02M-$48.23M-$70.45M
Shares outstanding97.49M97.41M97.23M41.58M36.06M36.06M36.06M35.94M
Cash flow statement
Operating cash flow-$22.90M-$20.80M-$28.68M-$18.53M-$18.25M-$19.54M-$21.49M-$18.24M
Capital expenditure$1.40M$648,000$137,000$397,000$772,000$537,000$248,000$363,000
Free cash flow-$24.29M-$21.45M-$28.82M-$18.92M-$19.02M-$20.07M-$21.74M-$18.60M
Investing cash flow-$1.40M-$648,000-$182,000-$397,000-$772,000-$537,000$1.11M-$364,000
Financing cash flow-$264,000-$877,000$299.51M$22.38M-$294,000-$442,000-$1.09M$78.40M
Depreciation & amortization$496,000$469,000$429,000$423,000$417,000$418,000$403,000$404,000
Stock-based compensation$1.40M$3.98M$1.82M$3.03M$1.60M$1.58M$1.70M$1.30M

Free plan shows the latest 8 periods; Pro shows all 11 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.